Inhibikase Therapeutics, Inc.IKTNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
0.00%
↑ 100% vs avg
Percentile
P25
Within normal range
Streak
2 yr
Consecutive growthStrong
Average
-2473.81%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.00% | +100.0% |
| 2023 | -7643.91% | +47.7% |
| 2022 | -14620.41% | - |
| 2021 | 0.00% | - |
| 2020 | 0.00% | - |
| 2019 | 0.00% | - |
| 2018 | 0.00% | - |
| 2017 | 0.00% | - |
| 2016 | 0.00% | - |